Status:

RECRUITING

Analgesic Efficacy of Erector Spinae Plane Block vs External Oblique Intercostal Plane Block in Subcostal Cancer Surgeries

Lead Sponsor:

National Cancer Institute, Egypt

Conditions:

Analgesia

Erector Spinae Plane Block

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study aims to evaluate the impact of ultrasound-guided erector spinae plane block compared to ultrasound-guided external oblique intercostal plane block regarding management of postoperative acut...

Detailed Description

Subcostal incisions in cancer surgeries as in hepatectomy and nephrectomy are a cause of severe pain and can lead to significant respiratory impairment. Regional anesthesia of the trunk and abdominal ...

Eligibility Criteria

Inclusion

  • Age (18-65) Years.
  • Both sexes.
  • Body mass index (BMI): (20-40) kg/m2.
  • American Society of Anesthesiology (ASA) physical status II, III.
  • Type of surgery; unilateral subcostal incision in hepatectomy and nephrectomy.

Exclusion

  • Patient refusal.
  • Subcostal incisions that are crossing the midline or midline incision.
  • Age \<18 years or \>65 years
  • BMI \<20 kg/m2 and \>40 kg/m2
  • Known sensitivity or contraindication to drugs used in the study
  • Contraindication to regional anesthesia e.g. local infection at the site of introduction, pre-existing peripheral neuropathies, and coagulopathy.
  • Pregnancy.
  • Physical status ASA IV
  • patients on chronic analgesic therapy (daily morphine ≥30 mg or equivalent dose of other opioids or tramadol or any medication for neuropathic pain)
  • patients with a history of drug abuse
  • patients with neuropsychiatric diseases; patients with a history of chronic pain syndromes that may enhance sensitivity to pain, for example, fibromyalgia
  • All patients who are going to have severe intra- or post-operative bleeding or will require postoperative mechanical ventilation are also excluded from the study.

Key Trial Info

Start Date :

July 25 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 27 2025

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06519708

Start Date

July 25 2024

End Date

May 27 2025

Last Update

July 26 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo University

Cairo, Egypt, 11796